Free Trial

Poolbeg Pharma (POLB) Competitors

Poolbeg Pharma logo
GBX 2.90 +0.05 (+1.75%)
As of 12:17 PM Eastern

POLB vs. REDX, ETX, FUM, SBTX, TRX, COS, C4XD, DDDD, OKYO, and SAR

Should you be buying Poolbeg Pharma stock or one of its competitors? The main competitors of Poolbeg Pharma include Redx Pharma (REDX), e-therapeutics (ETX), Futura Medical (FUM), SkinBioTherapeutics (SBTX), Tissue Regenix Group (TRX), Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), OKYO Pharma (OKYO), and Sareum (SAR). These companies are all part of the "biotechnology" industry.

Poolbeg Pharma vs. Its Competitors

Poolbeg Pharma (LON:POLB) and Redx Pharma (LON:REDX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, dividends, analyst recommendations, valuation, institutional ownership, earnings, profitability and risk.

Poolbeg Pharma's return on equity of -32.56% beat Redx Pharma's return on equity.

Company Net Margins Return on Equity Return on Assets
Poolbeg PharmaN/A -32.56% -21.33%
Redx Pharma N/A -180.80%-43.95%

1.2% of Poolbeg Pharma shares are held by institutional investors. Comparatively, 72.7% of Redx Pharma shares are held by institutional investors. 24.7% of Poolbeg Pharma shares are held by insiders. Comparatively, 18.4% of Redx Pharma shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Poolbeg Pharma has a beta of 2.11, suggesting that its share price is 111% more volatile than the S&P 500. Comparatively, Redx Pharma has a beta of -0.53, suggesting that its share price is 153% less volatile than the S&P 500.

Redx Pharma has higher revenue and earnings than Poolbeg Pharma. Poolbeg Pharma is trading at a lower price-to-earnings ratio than Redx Pharma, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Poolbeg PharmaN/AN/A-£4.50B-£851.820.00
Redx Pharma£4.20M0.00-£33.16M-£0.10N/A

In the previous week, Poolbeg Pharma's average media sentiment score of 0.00 equaled Redx Pharma'saverage media sentiment score.

Company Overall Sentiment
Poolbeg Pharma Neutral
Redx Pharma Neutral

Summary

Poolbeg Pharma beats Redx Pharma on 5 of the 9 factors compared between the two stocks.

Get Poolbeg Pharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for POLB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding POLB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

POLB vs. The Competition

MetricPoolbeg PharmaBiotechnology IndustryMedical SectorLON Exchange
Market Cap£14.91M£137.02M£5.70B£3.02B
Dividend YieldN/A3.74%4.69%5.02%
P/E Ratio0.003.7528.07160.63
Price / SalesN/A4,478.17448.57278,114.25
Price / Cash2.1113.1936.2227.97
Price / Book0.0042.328.664.69
Net Income-£4.50B-£90.99M£3.25B£5.90B
7 Day Performance-5.84%5.12%4.20%0.28%
1 Month Performance-11.59%9.52%10.82%8.61%
1 Year Performance-77.17%192.05%34.70%78.50%

Poolbeg Pharma Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
POLB
Poolbeg Pharma
N/AGBX 2.90
+1.8%
N/A-77.8%£14.91MN/A0.0012Gap Down
High Trading Volume
REDX
Redx Pharma
N/AN/AN/AN/A£58.35M£4.20M-150.00101Gap Up
High Trading Volume
ETX
e-therapeutics
N/AN/AN/AN/A£52.59M£295K-450.0035High Trading Volume
FUM
Futura Medical
N/AGBX 13.41
+1.0%
N/A-61.4%£41.79M£8.68M-11.0612Gap Up
High Trading Volume
SBTX
SkinBioTherapeutics
N/AGBX 16.34
-0.2%
N/A+48.3%£37.32M£1.56M-10.0511
TRX
Tissue Regenix Group
N/AGBX 36.44
-4.1%
N/A-42.4%£32.85M£31.98M-37.62120Gap Down
COS
Collagen Solutions plc (COS.L)
N/AN/AN/AN/A£30.99M£4.01M-8.283,350
C4XD
C4X Discovery
N/AN/AN/AN/A£30.27M£24.68M300.0049High Trading Volume
DDDD
4D pharma
N/AN/AN/AN/A£30.05M£718K-1.08106
OKYO
OKYO Pharma
N/AN/AN/AN/A£23.24MN/A-140.007Gap Down
SAR
Sareum
N/AGBX 18.60
-1.6%
N/A-41.1%£23.24MN/A-4.403,211Gap Down

Related Companies and Tools


This page (LON:POLB) was last updated on 7/25/2025 by MarketBeat.com Staff
From Our Partners